Literature DB >> 207435

Identification of a transformation-specific protein induced by a Rous sarcoma virus.

G Jay, R P Shiu, F T Jay, A S Levine, I Pastan.   

Abstract

Using antisera obtained from rats bearing Schmidt-Ruppin strain Rous sarcoma virus-induced tumors, we have idnetified a protein with an apparent molecular weight of 56,000 daltons and an isoelectric point of 6.3 in extracts of chick embryo fibroblasts transformed by a wild-type nondefective Rous sarcoma virus (Schmidt-Ruppin strain). This protein was not found in cells infected by trnasformation-defective mutants with either a partial or complete deletion of the src gene, nor in cells infected by a nontransforming avian leukosis virus. The 56,000 dalton molecular weight protein was found to be synthesized at both the permissive and nonpermissive temperatures in cells infected by either of two conditionallethal mutants that are temperature-sensitive in cell transformation. The amount of this protein, however, accumulated in cells infected by these temperature-sensitive mutants, relative to the structural polypeptides, differed significnatly from that seen with the nondefective virus. Pulsechase experiments indicate that the protein is extremely unstable, with a half-life of about 20 min, and does not serve as a precursor to any of the detectable virion polypeptides. Furthermore, incubation of the rat antiserum with purified, disrupted virus did not affect its immunoreactivity to this particular protein. We conclude that this 56,000 dalton molecular weight protein is a nonstructural protein specific to cells transformed by Rous sarcoma virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207435     DOI: 10.1016/0092-8674(78)90326-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  18 in total

1.  Processing of 60,000-dalton sarc gene protein synthesized by cell-free translation.

Authors:  J Kamine; J M Buchanan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

2.  Comparison of the expression of the src gene of Rous sarcoma virus in vitro and in vivo.

Authors:  B M Sefton; K Beemon; T Hunter
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

3.  Is the product of the src gene a promoter?

Authors:  M J Bissell; C Hatié; M Calvin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

4.  Cell-free synthesis of mouse H-2 histocompatibility antigens.

Authors:  G Jay; U Ferrini; E A Robinson; G Khoury; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

5.  Occurrence of a unique MHC class I gene in distantly related members of the genus Mus.

Authors:  D F Siwarski; Y Barra; G Jay; M J Rogers
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

6.  Effect of a tsA mutation of simian virus 40 late gene expression: variations between host cell lines.

Authors:  J C Alwine; G Khoury
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

7.  Control of simian virus 40 gene expression at the levels of RNA synthesis and processing: thermally induced changes in the ratio of the simian virus 40 early mRNA's and proteins.

Authors:  J C Alwine; G Khoury
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

8.  Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division.

Authors:  D W Shen; F X Real; A B DeLeo; L J Old; P A Marks; R A Rifkind
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.

Authors:  W L Maloy; J E Coligan; Y Barra; G Jay
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

10.  Mouse Lyt-2 antigen: evidence for two heterodimers with a common subunit.

Authors:  G Jay; M A Palladino; G Khoury; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.